InvestorsHub Logo
Followers 38
Posts 324
Boards Moderated 0
Alias Born 10/09/2013

Re: None

Saturday, 11/28/2015 9:36:18 AM

Saturday, November 28, 2015 9:36:18 AM

Post# of 34576
Listening to the video...interesting how the reporter mentions the "National cancer Institute" and how 5 billion dollars may have been spent in the wrong place.

Could Tapimmune be the right place?

Coincidentally Glynn has hinted on at least 2 occasions that they were going to announce a collaboration with not only a large BP but a cancer institute as well.

Just wondering if there may be a nice grant from the Cancer Institute, when they announce who those two collaborations are with.

After all the Institute has spent 5 billion in the "wrong places" as per the video, a nice 10 million or so grant may not be out of the question at all.

Glynn mentioned in the last CC that they are expecting a grant any time soon...seems to me to be quite a coincidence.

If they get involved, would be great to see then fund the HER2Nue trial and if they do come on board, may continue to fund till end of trials if the data continues to be stellar.

Remember folks they are nearing completion of the "commercial" vaccine which is supposed to be much more effective than the Phase 1 data vaccine.

As to the suppression of SP due to the warrants, most of us know this is at least a 2 year window "patience" the momentum is swinging our way.

I will reiterate, would not be surprised at all that with 2 Phase 11 trials up and running [mid 2016], grant funding, partnership with large BP and institute possible [funding], continued non-recurrence of disease, and Polystart Phase 1 initiation, and no debt and cash in bank, fast track status etc. That we do not receive one if not multiple offers to purchase the company.

Glynn looks quite excited in the video with Figueredo, each and every step of the way so far, they have accomplished, and exceeded their goal[s] .

The Tapimmune story is substantially better than the prior 2 companies that were bought out for 1 billion plus, scenario once again, 100 mill O/S [min possibly 120 max] within the mid 2016 timeframe $10 dollars plus. There may be a very real possibility of that scenario coming to fruition.

Would be great to see those sequence of events occur without a R/S, but if R/S does occur than with the reduced amount of shares and Dart's overwhelming ownership. SP mid 2016 should after up-listing to major exchange garner a much higher SP than $10.

Is it out of the question that Dart buys the company?

Let the bidding wars begin as the announcer says "For the first time ever, a Palm Beach County doctor is on the verge of one of the biggest medical breakthroughs of the century".


GLTA

BLU

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News